Hormonal profile, endometrial histology and ovarian ultrasound assessment during 1 year of nomegestrol acetate implant (Uniplant(R))

被引:19
作者
Devoto, L
Kohen, P
Barnhart, K
Alba, F
Pommer, R
Retamales, I
Coutinho, E
机构
[1] UNIV CHILE, SCH MED, DEPT OBSTET & GYNECOL, SANTIAGO, CHILE
[2] UNIV PENN, DEPT OBSTET & GYNECOL, DIV HUMAN REPROD, PHILADELPHIA, PA 19104 USA
[3] UNIV CHILE, SCH MED, HOSP SAN BORJA ARRIARAN, DEPT PATHOL, SANTIAGO, CHILE
[4] UNIV FED BAHIA, MATERN CLIMERIO OLIVEIRA, BR-41170290 SALVADOR, BA, BRAZIL
关键词
gonadotrophins; nomegestrol acetate subdermal implants; oestradiol; ovarian function; progesterone;
D O I
10.1093/humrep/12.4.708
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The present study assesses the endocrinological, endometrial histology and vaginal ultrasound profiles of nomegestrol acetate subdermal implant users at varying times after insertion, Follicle stimulatory hormone, luteinizing hormone, oestradiol, progesterone, vaginal ultrasound assessment of the ovaries and the histological dating of the endometrium were serially assessed for a period of 50 days immediately after the insertion, and after at 6 months and 12 months of use, The endocrinological results of this prospective observational clinical trial indicated that 75% of the cycles across the study period in Uniplant(R) users were anovulatory, 63% showing development of a persistent non-luteinized follicle, Anovulatory cycles devoid of follicular development were seen primarily in the first months after Uniplant insertion, Ovulatory cycles represented 25% of the Uniplant cycles, Inadequate luteal phase or disregulation of follicular growth was a common feature of ovulatory cycles, In conclusion, these findings suggest that the contraceptive mechanisms of a single nomegestrol acetate subdermal implant involve prevention of follicular growth, development of a persistent non-luteinized follicle, inadequate luteal phase and disruption of the endometrial architecture.
引用
收藏
页码:708 / 713
页数:6
相关论文
共 18 条
[1]   Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrol acetate (Uniplant) [J].
Barnhart, K ;
Devoto, L ;
Pommer, R ;
SirPettermann, T ;
Robinovic, J ;
Coutinho, E .
FERTILITY AND STERILITY, 1997, 67 (02) :250-255
[2]   ANOVULATION, INADEQUATE LUTEAL PHASE AND POOR SPERM PENETRATION IN CERVICAL-MUCUS DURING PROLONGED USE OF NORPLANT IMPLANTS [J].
BRACHE, V ;
FAUNDES, A ;
JOHANSSON, E ;
ALVAREZ, F .
CONTRACEPTION, 1985, 31 (03) :261-273
[3]   OVARIAN ENDOCRINE FUNCTION THROUGH 5 YEARS OF CONTINUOUS TREATMENT WITH NORPLANT SUBDERMAL CONTRACEPTIVE IMPLANTS [J].
BRACHE, V ;
ALVAREZSANCHEZ, F ;
FAUNDES, A ;
TEJADA, AS ;
COCHON, L .
CONTRACEPTION, 1990, 41 (02) :169-177
[4]   TITRATING LUTEINIZING-HORMONE SURGE REQUIREMENTS FOR OVULATORY CHANGES IN PRIMATE FOLLICLES .2. PROGESTERONE-RECEPTOR EXPRESSION IN LUTEINZING GRANULOSA-CELLS [J].
CHANDRASEKHER, YA ;
BRENNER, RM ;
MOLSKNESS, TA ;
YU, Q ;
STOUFFER, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (03) :584-589
[5]  
COUTINHO EM, 1993, CONTRACEPTION, V47, P94
[6]   TREATMENT WITH NORPLANT SUBDERMAL IMPLANTS INHIBITS SPERM PENETRATION THROUGH CERVICAL-MUCUS INVITRO [J].
CROXATTO, HB ;
DIAZ, S ;
SALVATIERRA, AM ;
MORALES, P ;
EBENSPERGER, C ;
BRANDEIS, A .
CONTRACEPTION, 1987, 36 (02) :193-201
[7]  
DEVOTO L, 1989, FERTIL STERIL, V51, P628
[8]  
DEVOTO L, 1995, CONTRACEPT FERTIL S, P146
[9]  
DOODY MC, 1987, FERTIL STERIL, V47, P436
[10]  
FAUNDES A, 1991, FERTIL STERIL, V56, P27